IVIS Revvity Optical Imaging Equipment
The IVIS Spectrum system is a preclinical optical imaging system that enables non-invasive visualization and tracking of biological processes in live animals, using both bioluminescence and fluorescence. This advanced system combines 2D bioluminescence imaging, 2D fluorescence imaging, and 3D optical tomography in a single platform, facilitating comprehensive analysis.
Bioluminescence and fluorescence provide unique features for imaging small animals:
Bioluminescence imaging (BLI) uses luciferase genes, which produce minimal background signals from animal tissues. This provides high specificity and accurate quantification, making it ideal for detecting and monitoring biological events, such as tumor growth deep within tissue.
* Fluorescence imaging (FLI) is perfect for monitoring and quantifying the cellular behavior of specific biological targets.
* This equipment provides the sensitivity needed for non-invasive longitudinal imaging, allowing for the understanding of early biological changes related to various diseases, tracking their progression, and supporting the development of new drugs more efficiently.
On-demand access to this non-unique infrastructure requires the user to complete the following Service Request Form, which must be submitted to BioImaC, duly completed by the Principal Investigator or a person authorized by him/her.
Bioluminescence and fluorescence provide unique features for imaging small animals:
Bioluminescence imaging (BLI) uses luciferase genes, which produce minimal background signals from animal tissues. This provides high specificity and accurate quantification, making it ideal for detecting and monitoring biological events, such as tumor growth deep within tissue.
* Fluorescence imaging (FLI) is perfect for monitoring and quantifying the cellular behavior of specific biological targets.
* This equipment provides the sensitivity needed for non-invasive longitudinal imaging, allowing for the understanding of early biological changes related to various diseases, tracking their progression, and supporting the development of new drugs more efficiently.
On-demand access to this non-unique infrastructure requires the user to complete the following Service Request Form, which must be submitted to BioImaC, duly completed by the Principal Investigator or a person authorized by him/her.
On-demand access request form |
ICTS Complutense Bioimaging
|
